Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method

BACKGROUND: Polypharmacy for schizophrenia treatment is not justified by the available clinical evidence. We evaluated a treatment reduction approach that reduces the dose and number of antipsychotic medications simultaneously prescribed to patients. METHODS: In a randomized open study of the Safe C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamanouchi, Yoshio, Sukegawa, Tsuruhei, Inagaki, Ataru, Inada, Toshiya, Yoshio, Takashi, Yoshimura, Reiji, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376537/
https://www.ncbi.nlm.nih.gov/pubmed/25522380
http://dx.doi.org/10.1093/ijnp/pyu016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376537/
https://www.ncbi.nlm.nih.gov/pubmed/25522380
http://dx.doi.org/10.1093/ijnp/pyu016

Ejemplares similares